Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%. Read why I downgrade HIMS stock from buy to ...

And if earnings estimates go up for a company ... paying attention to the market buzz about Hims & Hers Health. However, its Zacks Rank #3 does suggest that it may perform in line with the ...

“Hims’ Super Bowl ad does not promote a specific drug or medication ... and stay on treatment up to 3 times longer than the industry standard.” Hims & Hers also said in its statement that ...

A telehealth company that sells a compounded version of medications used for weight loss has found itself at the center of an ...

Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...

The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.

Hims & Hers Health (NYSE:HIMS) is surging today. The stock is up 19%, and this is part of a ... It is expected to show 89-91% year-over-year revenue growth, with analysts forecasting $0.21 EPS ...

Hims compiled a list of the top 25 U.S. counties for dating based on the number of single households, median age, restaurant ...